Search:

Uncovering the Truth In Trasylol

By: Peter Kent Trasylol Aprotinin is a blood-controlling injectable drug administered to patients undergoing heart surgery. After its initial release, it was praised by the medical community, but within only a few months studies and reports of the drugs severely damaging side effects came to light; exposing the truth of trasylol.

The drug, which is manufactured by Bayer AG and was approved in the United States in 1993, had been questioned in a January 2006 report by the New England Journal of Medicine, which found that Trasylol upped the risk of kidney failure after heart surgery by 259 percent and linked the drug with renal failure and future heart attacks.

Singing Its Praises

Ironically, the drug had been mentioned in The Washington Post in early January 2006 as an example of a drug so safe that it no longer required clinical study. The article stated that Trasylol dropped the risk of blood transfusions in bypass patients by one-third and that after only 12 of 64 clinical studies, its advantages were clear. Amazingly, the article stated that if researchers had used the positive information from previous studies, they would not have needed to run their own clinical trials.

Tides Turn for Trasylol

The above article ran on January 2, 2006. However, in only 24 days, the tide had turned for Trasylol after the New England Journal of Medicine published its study of over 1,000 heart patients who received injections of Trasylol-Aprotinin. Once the study was published, the U.S. Food and Drug Administration (FDA) began investigating the alleged side effects and, even after protests by Bayer officials claiming the results of the study were inaccurate, the FDA began discouraging the use of Trasylol-Aprotinin among patients.

Though Bayer has tried to discredit this study and market the drug for other procedures (including hip replacement surgery), lawsuits have begun to flow in as more and more patients have been found who have experienced detrimental side effects from the use of Trasylol-Aprotinin in their heart surgeries.

Have You Suffered Side Effects?

Gaining the perspective of an experience pharmaceutical attorney who can consult you on your experience with Trasylol-Aprotinin will allow the potential for monetary compensation for the costly medical bills attributed to these damaging side effects. Contact an experienced pharmaceutical attorney who can help you evaluate your claim and attain the compensation you deserve.

Article Source: http://www.lifeweightloss.com

Use trasylol-aprotinin.legalview.com to garner more information on this ongoing investigation. Also use LegalView's other information portals to learn about controversial drugs similar to Trasylol Aprotinin such as the Avandia risks, found at avandia.legalview.com, or the Vytorin and Zetia side effects.

Please Rate this Article

Not yet Rated